| Mrs Aliza Zissel Schwab, | |
|
19 Portina Rd, Brighton, MA 02135-4618 | |
| (516) 640-0882 | |
| Not Available |
| Full Name | Mrs Aliza Zissel Schwab |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 19 Portina Rd, Brighton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295016996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Aliza Zissel Schwab, 19 Portina Rd, Brighton, MA 02135-4618 Ph: (516) 640-0882 | Mrs Aliza Zissel Schwab, 19 Portina Rd, Brighton, MA 02135-4618 Ph: (516) 640-0882 |
News Archive
A study by the University of Konstanz shows that voluntary motivation to comply with anti-Covid-19 policies is relatively high in Germany, but can be undermined by enforcement - The consequence of this finding differs depending on the policy
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration has approved ASTAGRAF XLTM (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil and corticosteroids, with or without basiliximab induction.
Even super heroes need a chance to get better, especially if they've been fighting their arch-nemesis and a robotic crab that just won't go away. At least, that's the premise behind a video game developed at the University of Utah to help children with cancer during their treatment.
The difference between merely throwing around buzzwords like "personalized medicine" and "big data" and delivering on their medical promise is in the details of developing methods for analyzing and interpreting genomic data. In a pair of new papers, Brown University epidemiologist Yen-Tsung Huang and colleagues show how integrating different kinds of genomic data could improve studies of the association between genes and disease.
Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.
› Verified 3 days ago
Ms. Margaret Arcuni Huber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-562-7735 | |
Sara Elizabeth Gardner, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 242 Corey Rd, Brighton, MA 02135 Phone: 203-241-1926 | |
Julia Martine Rifkin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Viktoriya Berdichevsky, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Mrs. Svetlana Piliavsky, MED-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 170 Corey Rd, Brighton, MA 02135 Phone: 617-383-6624 | |
Jennifer S Bartecchi, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-779-1626 |